Bengo Labs Inc. has developed a range of immunoaffinity ligands, positioned to change downstream bioprocessing of MAb’s and other biologics.
These ligands are currently under evaluation at number of academic institutions, as well as cGMP manufacturers, and affinity resin manufacturers.
